scispace - formally typeset
P

P S Virdee

Researcher at University of Oxford

Publications -  24
Citations -  487

P S Virdee is an academic researcher from University of Oxford. The author has contributed to research in topics: Colorectal cancer & Medicine. The author has an hindex of 6, co-authored 15 publications receiving 266 citations.

Papers
More filters
Journal ArticleDOI

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Harpreet Wasan, +197 more
- 01 Sep 2017 - 
TL;DR: Data suggest selective internal radiotherapy (SIRT) in third-line or subsequent therapy for metastatic colorectal cancer has clinical benefit in patients with coloreCTal liver metastases with liver-dominant disease after chemotherapy.
Journal ArticleDOI

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

Obbina Abani, +7885 more
- 03 Mar 2022 - 
TL;DR: In patients hospitalised with COVID-19, baricitinib significantly reduced the risk of death but the size of benefit was somewhat smaller than that suggested by previous trials.
Journal ArticleDOI

Overall survival analysis of the FOXFIRE prospective randomized studies of first-line selective internal radiotherapy (SIRT) in patients with liver metastases from colorectal cancer.

Ricky A. Sharma, +17 more
- 30 May 2017 - 
TL;DR: The primary endpoint of the FOXFIRE, SIRFLOX andFF-SF-FFG randomized studies evaluated the efficacy of combining first-line chemotherapy for metastatic colorectal cancer with selec...
Journal ArticleDOI

Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal Cancer.

P S Virdee, +8 more
- 28 Mar 2017 - 
TL;DR: In this paper, the authors evaluated the impact of SIRT combined with chemotherapy on overall survival in the first-line treatment of metastatic colorectal cancer in a randomized clinical trial.
Journal ArticleDOI

Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer.

Maxwell Robinson, +9 more
- 01 Feb 2020 - 
TL;DR: Volumes of active bone marrow receiving 20 Gy are associated with blood count nadirs and no suppression shown in un-irradiation bone marrow in on-treatment FDG-PET.